Aptevo Therapeutics (APVO) Share-based Compensation (2015 - 2026)
Aptevo Therapeutics (APVO) reported Share-based Compensation of $58,000 for Q2 2026, compared with -$163,000 a year earlier and up 1.8% from the prior quarter.
Powered by 
Analysis
Aptevo Therapeutics (APVO) Share-based Compensation (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Aptevo Therapeutics' Share-based Compensation came in at $194,000, up 106.4% year-over-year; for FY2025, it was $96,000, down 91.0% from FY2024.
- Share-based Compensation has a five-year compound annual growth rate of -40.2% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $1.07 million in FY2024 (-51.3%), $2.19 million in FY2023 (+21.7%), $1.8 million in FY2022 (+9.7%) and $1.64 million in FY2021 (+30.9%).
- Five-year quarterly Share-based Compensation spans a low of -$163,000 in Q2 2025 and a high of $915,000 in Q1 2023.
- The high point for year-over-year Share-based Compensation in five years was Q4 2022 (growth of 100.6%); the low point was Q1 2025 (a decline of 75.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $57,000 (Q1 2026), $2,000 (Q4 2025) and $77,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.13 Bn | 1,102.72 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 616.20 Bn | 534.73 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 297.88 Bn | 261.87 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.36 Bn | 235.05 Bn | 12.86 Bn | - |
| 7 | Amgen | 235.80 Bn | 191.20 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 190.78 Bn | 164.97 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 169.43 Bn | 116.08 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Aptevo Therapeutics | 1.94 Mn | -65.06 Mn | - | 20,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Sep 30, 2025 | 80,000.00 |
| Jun 30, 2025 | -180,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | -72,000.00 |
| Sep 30, 2024 | 149,000.00 |
| Jun 30, 2024 | 273,000.00 |
| Mar 31, 2024 | 719,000.00 |
| Dec 31, 2023 | 358,000.00 |
| Sep 30, 2023 | 455,000.00 |
| Jun 30, 2023 | 465,000.00 |
| Mar 31, 2023 | 915,000.00 |
| Dec 31, 2022 | 357,000.00 |
| Sep 30, 2022 | 359,000.00 |
| Jun 30, 2022 | 484,000.00 |
| Mar 31, 2022 | 601,000.00 |
| Dec 31, 2021 | 178,000.00 |
| Sep 30, 2021 | 319,000.00 |
API Access
Aptevo Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=APVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "APVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=APVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();